Tower Research Capital (TRC)’s CareMax, Inc. Class A Common Stock CMAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-5,118
Closed -$8.7K 6206
2024
Q3
$8.7K Sell
5,118
-55
-1% -$167 ﹤0.01% 3937
2024
Q2
$14.4K Buy
5,173
+3,332
+181% +$10.4K ﹤0.01% 3948
2024
Q1
$8.87K Buy
1,841
+1,141
+163% +$9.59K ﹤0.01% 3941
2023
Q4
$10.5K Buy
700
+525
+300% +$21.8K ﹤0.01% 4244
2023
Q3
$11.1K Buy
175
+77
+79% +$5.39K ﹤0.01% 4036
2023
Q2
$9.13K Sell
98
-54
-36% -$4.76K ﹤0.01% 4330
2023
Q1
$12K Buy
152
+68
+81% +$7.95K ﹤0.01% 4171
2022
Q4
$9K Sell
84
-88
-51% -$13.2K ﹤0.01% 4350
2022
Q3
$36K Buy
172
+31
+22% +$6.26K ﹤0.01% 3463
2022
Q2
$15K Buy
+141
New +$24.2K ﹤0.01% 4119
2021
Q2
Hold
0
6353
2021
Q1
Hold
0
6074

Other funds holding CMAX

Tower Research Capital (TRC)'s CMAX Position: Q4 2024 in Review

Tower Research Capital (TRC) sold out of CareMax, Inc. Class A Common Stock (CMAX) in Q4 2024, closing a stake of 5,118 shares — an estimated $8.7K sold.

Tower Research Capital (TRC) first reported a position in CMAX in Q2 2022 and held it in 10 quarters. The position peaked at $36K in Q3 2022. 4 funds tracked by Wall St. Rank hold CMAX as of Q4 2024.

  • Tower Research Capital (TRC) reported no remaining CareMax, Inc. Class A Common Stock position as of Q4 2024 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 5,118 CareMax, Inc. Class A Common Stock shares in Q4 2024, an estimated $8.7K.
  • Tower Research Capital (TRC) first reported a position in CareMax, Inc. Class A Common Stock in Q2 2022 and held it in 10 quarters.
  • Tower Research Capital (TRC)'s CareMax, Inc. Class A Common Stock position peaked at $36K in Q3 2022.
  • 4 funds tracked by Wall St. Rank held CareMax, Inc. Class A Common Stock as of Q4 2024.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2024, filed 13 Feb 2025.